CN1308442C - 纯化酶的方法和按此产生出的经纯化的酶以及该酶的用途 - Google Patents

纯化酶的方法和按此产生出的经纯化的酶以及该酶的用途 Download PDF

Info

Publication number
CN1308442C
CN1308442C CNB028131347A CN02813134A CN1308442C CN 1308442 C CN1308442 C CN 1308442C CN B028131347 A CNB028131347 A CN B028131347A CN 02813134 A CN02813134 A CN 02813134A CN 1308442 C CN1308442 C CN 1308442C
Authority
CN
China
Prior art keywords
collagenase
type
chromatography
elution
clostripain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB028131347A
Other languages
English (en)
Chinese (zh)
Other versions
CN1529751A (zh
Inventor
M·库菲尔斯特
S·施米德鲍尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Normark Pharmaceutical Co ltd
Normark Pharmaceutical Holdings Co ltd
Original Assignee
Nordmark Arzneimittel GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10134347A external-priority patent/DE10134347B4/de
Application filed by Nordmark Arzneimittel GmbH and Co KG filed Critical Nordmark Arzneimittel GmbH and Co KG
Publication of CN1529751A publication Critical patent/CN1529751A/zh
Application granted granted Critical
Publication of CN1308442C publication Critical patent/CN1308442C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22008—Clostripain (3.4.22.8)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CNB028131347A 2001-07-02 2002-06-01 纯化酶的方法和按此产生出的经纯化的酶以及该酶的用途 Expired - Lifetime CN1308442C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10131994.0 2001-07-02
DE10131994 2001-07-02
DE10134347A DE10134347B4 (de) 2001-07-02 2001-07-14 Verfahren zur Aufreinigung eines Enzyms
DE10134347.7 2001-07-14

Publications (2)

Publication Number Publication Date
CN1529751A CN1529751A (zh) 2004-09-15
CN1308442C true CN1308442C (zh) 2007-04-04

Family

ID=26009625

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028131347A Expired - Lifetime CN1308442C (zh) 2001-07-02 2002-06-01 纯化酶的方法和按此产生出的经纯化的酶以及该酶的用途

Country Status (8)

Country Link
US (1) US7083964B2 (enExample)
EP (1) EP1402008B1 (enExample)
JP (1) JP4266817B2 (enExample)
CN (1) CN1308442C (enExample)
AT (1) ATE302844T1 (enExample)
AU (1) AU2002354696A1 (enExample)
CA (1) CA2447818C (enExample)
WO (1) WO2003004628A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
DE10331171A1 (de) * 2003-07-09 2005-01-27 Nordmark Arzneimittel Gmbh & Co. Kg Neutrale Protease (NP) und Produkt unter Verwendung von neutraler Protease für Gewebedissoziation sowie Verfahren zu dessen Herstellung
US7824711B2 (en) 2003-12-11 2010-11-02 Isto Technologies, Inc. Particulate cartilage system
EP1916964A4 (en) 2005-08-26 2015-11-04 Zimmer Inc IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES
US20070181479A1 (en) * 2005-11-21 2007-08-09 Pentax Corporation Column and method of manufacturing the column
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
AU2008240191B2 (en) 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
US8853261B2 (en) * 2008-01-21 2014-10-07 Laila Nutraceuticals Nutraceutical composition from Garcinia mangostana
EP2130551B1 (en) 2008-06-02 2012-06-06 Roche Diagnostics GmbH Improved purification of collagenases from clostridium histolyticum liquid culture
EP4015627B1 (en) 2012-01-12 2023-09-27 Endo Global Ventures Clostridium histolyticum enzyme
US9636385B2 (en) 2012-10-24 2017-05-02 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
GB201507207D0 (en) * 2015-04-24 2015-06-10 Givaudan Sa Enzymes and applications thereof
KR20230003601A (ko) 2017-03-01 2023-01-06 엔도 벤쳐즈 리미티드 셀룰라이트를 평가하고 치료하기 위한 장치 및 방법
KR20240001279A (ko) 2017-03-28 2024-01-03 엔도 벤쳐즈 리미티드 개선된 콜라게나제 생성 방법
CN112996801A (zh) * 2018-11-26 2021-06-18 北卡罗来纳州大学 用于捕获宿主细胞蛋白的肽配体
JP2022529565A (ja) * 2019-02-14 2022-06-23 ノルドマルク ファーマ ゲーエムベーハー コラゲナーゼタイプｉ、コラゲナーゼタイプｉｉ、中性プロテアーゼ、およびクロストリパインからなる群から選択される少なくとも１種の酵素のクロマトグラフィー精製

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332503A (en) * 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4445891A1 (de) * 1994-12-22 1996-06-27 Boehringer Mannheim Gmbh Rekombinante Proteinase aus Clostridium histolyticum und ihre Verwendung zur Isolierung von Zellen und Zellverbänden

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332503A (en) * 1993-04-16 1994-07-26 Baxter International Inc. Process for purifying collagenase

Also Published As

Publication number Publication date
EP1402008B1 (de) 2005-08-24
JP2004535197A (ja) 2004-11-25
US7083964B2 (en) 2006-08-01
ATE302844T1 (de) 2005-09-15
WO2003004628A2 (de) 2003-01-16
JP4266817B2 (ja) 2009-05-20
AU2002354696A1 (en) 2003-01-21
CN1529751A (zh) 2004-09-15
US20040137596A1 (en) 2004-07-15
EP1402008A2 (de) 2004-03-31
CA2447818A1 (en) 2003-01-16
CA2447818C (en) 2011-01-04
WO2003004628A3 (de) 2003-09-18

Similar Documents

Publication Publication Date Title
CN1308442C (zh) 纯化酶的方法和按此产生出的经纯化的酶以及该酶的用途
JP4559216B2 (ja) 液体中の夾雑物からアルブミンを分離する方法、使用及びキット
Kaufmann Unstable proteins: how to subject them to chromatographic separations for purification procedures
KR0139209B1 (ko) 단백질 정제방법
JP2004535197A5 (enExample)
US4264738A (en) Process for purification of proteolytic enzymes
JP3662020B2 (ja) コラゲナーゼを精製する方法
Fernández-Lahore et al. Acid protease recovery from a solid-state fermentation system
Van Den Burg et al. One-step affinity purification of Bacillus neutral proteases using bacitracin-silica
Stepanov et al. Affinity chromatography of proteolytic enzymes on silica-based biospecific sorbents
EP1343873B1 (en) A method for the purification of chymosin
JP3833255B2 (ja) タンパク質の精製方法
Ke et al. Preparation of the immobilized metal affinity membrane with high amount of metal ions and protein adsorption efficiencies
EP1507858B1 (en) Method for the purification of a rhizomucor aspartic protease
KR100493835B1 (ko) 뱀독액으로부터 수득되는 트롬빈 유사 프로테아제 효소의 정제방법
JP2833811B2 (ja) ウロキナーゼ化合物の回収
US20220135617A1 (en) Chromatographic purification of at least one enzyme selected from a group including collagenase type i, collagenase type ii, neutral protease and clostripain
Schwidop et al. Procedure for the purification of streptavidin by hydrophobic interaction chromatography
Turchi et al. Improved purification of α-amylase isolated from Rhizomucor pusillus by affinity chromatography
Harsa et al. Separation of amyloglucosidase using β-cyclodextrin/chitosan
Hatti-Kaul et al. Downstream processing of proteins from transgenic plants
BRPI0210106B1 (pt) Processo para a purificação de caseinase, colagenases dos tipos i e ii e clostripaína produzidas em um meio pela fermentação de clostridium histolyticum
Gribnau et al. Application of the FCP-activation procedure to the synthesis of a biospecific adsorbent for trypsin
GB2031432A (en) Purification of proteolytic enzymes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP01 Change in the name or title of a patent holder

Address after: German Uetersen

Patentee after: Normark Pharmaceutical Holdings Co.,Ltd.

Address before: German Uetersen

Patentee before: NORDMARK ARZNEINMITTEL GmbH & Co.KG

CP01 Change in the name or title of a patent holder
TR01 Transfer of patent right

Effective date of registration: 20210831

Address after: German Uetersen

Patentee after: Normark Pharmaceutical Co.,Ltd.

Address before: German Uetersen

Patentee before: Normark Pharmaceutical Holdings Co.,Ltd.

TR01 Transfer of patent right
CX01 Expiry of patent term

Granted publication date: 20070404

CX01 Expiry of patent term